Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction.

Published

Journal Article

OBJECTIVES: This study characterized clinical factors predictive of cardiogenic shock developing after thrombolytic therapy for acute myocardial infarction (AMI). BACKGROUND: Cardiogenic shock remains a common and ominous complication of AMI. By identifying patients at risk of developing shock, preventive measures may be implemented to avert its development. METHODS: We analyzed baseline variables associated with the development of shock after thrombolytic therapy in the Global Utilization of Streptikonase and Tissue-Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. Using a Cox proportional hazards model, we devised a scoring system predicting the risk of shock. This model was then validated in the Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO-III) cohort. RESULTS: Shock developed in 1,889 patients a median of 11.6 h after enrollment. The major factors associated with increased adjusted risk of shock were age (chi2 = 285, hazard ratio [95% confidence interval] 1.47 [1.40, 1.53]), systolic blood pressure (chi2 = 280), heart rate (chi2 = 225) and Killip class (chi2 = 161, hazard ratio 1.70 [1.52, 1.90] and 2.95 [2.39, 3.63] for Killip II versus I and Killip III versus I, respectively) upon presentation. Together, these four variables accounted for >85% of the predictive information. These findings were transformed into an algorithm with a validated concordance index of 0.758. Applied to the GUSTO-III cohort, the four variables accounted for > 95% of the predictive information, and the validated concordance index was 0.796. CONCLUSIONS: A scoring system accurately predicts the risk of shock after thrombolytic therapy for AMI based primarily on the patient's age and physical examination on presentation.

Full Text

Duke Authors

Cited Authors

  • Hasdai, D; Califf, RM; Thompson, TD; Hochman, JS; Ohman, EM; Pfisterer, M; Bates, ER; Vahanian, A; Armstrong, PW; Criger, DA; Topol, EJ; Holmes, DR

Published Date

  • January 2000

Published In

Volume / Issue

  • 35 / 1

Start / End Page

  • 136 - 143

PubMed ID

  • 10636271

Pubmed Central ID

  • 10636271

International Standard Serial Number (ISSN)

  • 0735-1097

Language

  • eng

Conference Location

  • United States